Literature DB >> 26998875

Intracellular interactions of electrostatically mediated layer-by-layer assembled polyelectrolytes based sorafenib nanoparticles in oral cancer cells.

Radhika Poojari1, Sudarshan Kini2, Rohit Srivastava2, Dulal Panda3.   

Abstract

In this paper, we report the preparation of LbL-nanoSraf (100-300nm) comprising of layer-by-layer (LbL) assembled polyelectrolytes dextran-sulfate/poly-l-arginine, with a multikinase inhibitor sorafenib (Sraf) encapsulated calcium carbonate (CaCO3) nanoparticles for oral cancer therapy in vitro. The zeta potential of LbL-nanoSraf exhibited a negative charge of the polyanionic dextran sulfate, which alternated with a positive charge of polycationic poly-l-arginine indicating a successful LbL assembly of the two polyelectrolyte bilayers on the CaCO3 nanoparticles. The LbL-nanoSraf exhibited an encapsulation efficiency of 61±4%. The LbL-nanoSraf was characterized using field-emission gun scanning electron microscopy, X-ray powder diffraction, atomic force microscopy and confocal laser scanning microscopy. Confocal laser scanning microscopy, flow cytometry and transmission electron microscopic investigations showed the internalization of LbL-nanoSraf in human oral cancer (KB) cells. The LbL-nanoSraf exhibited more potent antiproliferative, apoptotic and antimigratory activities in KB cells than the free drug Sraf. The findings could promote the application of nano-sized LbL assembled polyelectrolytes for the delivery of Raf-kinase inhibitors and provide mechanistic insights for oral cancer therapy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium carbonate nanoparticles; Kinase inhibitor; Layer-by-layer assembled polyelectrolytes; Oral cancer cells; Sorafenib

Mesh:

Substances:

Year:  2016        PMID: 26998875     DOI: 10.1016/j.colsurfb.2016.03.024

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.

Authors:  Tong Li; Yu Zhang; Yuan-Pu Meng; Li-Shan Bo; Wen-Bo Ke
Journal:  Pharm Res       Date:  2017-11-27       Impact factor: 4.200

2.  Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery.

Authors:  Sebastien Benizri; Ludivine Ferey; Bruno Alies; Naila Mebarek; Gaelle Vacher; Ananda Appavoo; Cathy Staedel; Karen Gaudin; Philippe Barthélémy
Journal:  Nanoscale Res Lett       Date:  2018-01-11       Impact factor: 4.703

3.  MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.

Authors:  Fei Xu; Ming-Liang Ye; Yu-Peng Zhang; Wen-Jie Li; Meng-Ting Li; Hai-Zhou Wang; Xiao Qiu; Yan Xu; Jin-Wen Yin; Qian Hu; Wan-Hui Wei; Ying Chang; Lan Liu; Qiu Zhao
Journal:  Cancer Sci       Date:  2020-03-14       Impact factor: 6.716

4.  Amphiphilic small molecular mates match hydrophobic drugs to form nanoassemblies based on drug-mate strategy.

Authors:  Leiqiang Han; Shuang Liang; Weiwei Mu; Zipeng Zhang; Limin Wang; Shumin Ouyang; Bufan Yao; Yongjun Liu; Na Zhang
Journal:  Asian J Pharm Sci       Date:  2021-11-30       Impact factor: 6.598

Review 5.  Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.

Authors:  Fangmin Chen; Yifan Fang; Xiang Chen; Rui Deng; Yongjie Zhang; Jingwei Shao
Journal:  Asian J Pharm Sci       Date:  2020-08-21       Impact factor: 6.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.